Global /South Korea /Healthcare /Drug Manufacturers - General /019170

Shinpoong Pharmaceutical Co.,Ltd

019170

• KRX: 019170 • Delayed

11,690KRW -1.9%

7.49 USD

As of 6 June 2026, Shinpoong Pharmaceutical Co.,Ltd has a market cap of $403.29M USD, ranking #16631 globally and #521 in South Korea. It ranks #1508 in the Healthcare sector, and #548 in the Drug Manufacturers - General industry.

Global Rank

16631

Country Rank

521

Sector Rank

1508

Industry Rank

548

Key Stats

Market Cap

$403.29MUSD

618.16B KRW

Enterprise Value

$386.72MUSD

603.27B KRW

Revenue (TTM)

$153.1MUSD

234.68B KRW

EBITDA (TTM)

$16.44MUSD

25.65B KRW

Net Income (TTM)

$5.76MUSD

8.83B KRW

EBITDA Margin

11%

Profit Margin

3.8%

PE Ratio

69.2

PS Ratio

2.6

PB Ratio

2.3

EV/EBITDA

23.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jei-Man Ryu open_in_new

Employees

809

Founded

1962

Website

shinpoong.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.9%	3%	8%	-10%	-24%	-15%	57%	-34%	-85%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	019170 신풍제약(주) ISIN: KR7019170000 Shares Out.: Shares Outstanding: 51.708M¹ Shares Float: 35.276M² TV: TradingView: KRX: 019170 SA: Stock Analysis: KRX: 019170 YF: Yahoo Finance: 019170.KS GF: Google Finance: KRX: 019170 BA: Barron's: 019170 MS: Morningstar: XKRX: 019170	11,690 KRW	TV: TradingView: KRX: 019170 SA: Stock Analysis: KRX: 019170 YF: Yahoo Finance: 019170.KS GF: Google Finance: KRX: 019170 BA: Barron's: 019170 MS: Morningstar: XKRX: 019170
Korea Exchange (KRX) MIC: XKRX	019175 신풍제약(주) ISIN: KR7019171008 TV: TradingView: KRX: 019175 SA: Stock Analysis: KRX: 019175 YF: Yahoo Finance: 019175.KS GF: Google Finance: KRX: 019175 BA: Barron's: 019175 MS: Morningstar: XKRX: 019175	16,700 KRW	TV: TradingView: KRX: 019175 SA: Stock Analysis: KRX: 019175 YF: Yahoo Finance: 019175.KS GF: Google Finance: KRX: 019175 BA: Barron's: 019175 MS: Morningstar: XKRX: 019175

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shinpoong Pharmaceutical Co.,Ltd

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.07B 13.91T KRW 2K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.72B 10.3T KRW 2K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.2B 7.97T KRW 1K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.92B 7.55T KRW 1K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.51B 6.92T KRW 1K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.41B 6.76T KRW 993%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 189K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 136K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 89K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 80K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 72K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 69K%	20.5	Switzerland

chevron_leftBack